SCM LIFESCIENCE CO., LTD. SCM Lifescience Co., Ltd. Share Price
Equities
A298060
KR7298060005
Biotechnology & Medical Research
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,760 KRW | -1.95% |
|
-8.91% | -26.98% |
| 2023 | SCM Lifescience Co., Ltd.(KOSDAQ:A298060) dropped from S&P Global BMI Index | CI |
| 2023 | SCM LifeScience to Raise 30.9 Billion Won via Share Issuance | MT |
| Sales 2022 | 40Cr 3L 2.38Cr | Sales 2023 | 70Cr 5L 4.18Cr | Capitalization | 7.74TCr 5.58Cr 465.13Cr |
|---|---|---|---|---|---|
| Net income 2022 | -2.29TCr -1.65Cr -137.86Cr | Net income 2023 | -2.4TCr -1.73Cr -144.06Cr | EV / Sales 2022 | 434 x |
| Net cash position 2022 | 320.07Cr 23.08L 19Cr | Net cash position 2023 | 851.75Cr 61.41L 51Cr | EV / Sales 2023 | 99 x |
| P/E ratio 2022 |
-6.35
x | P/E ratio 2023 |
-2.58
x | Employees | - |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 82.26% |
More Fundamentals
* Assessed data
More news
More press releases
| 1 day | -1.95% | ||
| 1 week | -8.91% | ||
| Current month | -4.66% | ||
| 1 month | -6.76% | ||
| 3 months | -7.38% | ||
| 6 months | -13.88% | ||
| Current year | -26.98% |
1 week
2 745.00
2 945.00
1 month
2 745.003 135.00
Current year
2 520.004 300.00
1 year
2 060.005 758.33
3 years
2 060.0029 375.00
5 years
2 060.0050 250.00
10 years
2 060.0050 250.00
| Managers | Title | Age | Since |
|---|---|---|---|
Suk-Woo Oh
COO | Chief Operating Officer | - | - |
Sun-Wook Song
CTO | Chief Tech/Sci/R&D Officer | - | 02/14/02 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 21/24/21 | 2,760 | -1.95% | 33,147 |
| 20/24/20 | 2,815 | +0.36% | 49,368 |
| 19/24/19 | 2,805 | -1.75% | 79,921 |
| 18/24/18 | 2,855 | -3.06% | 65,251 |
| 17/24/17 | 2,945 | -2.81% | 121,757 |
End-of-day quote Korea S.E., June 21, 2024
More quotes
SCM Lifescience Co Ltd is a Korea-based company engaged in the research and development of medicines. The Company is engaged in the business of the development and production of cell therapy products, the agency testing of cell production and quality, adult stem cell consulting, cosmetics manufacturing, and hair growth protein manufacturing.
Calendar
09/08/2024
- Q2 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -26.98% | 4.06Cr | |
| +15.19% | 12TCr | |
| +19.91% | 11TCr | |
| +18.37% | 2.36TCr | |
| -19.80% | 2.04TCr | |
| -15.66% | 1.65TCr | |
| -13.45% | 1.64TCr | |
| -44.35% | 1.56TCr | |
| +66.67% | 1.52TCr | |
| +2.13% | 1.35TCr |
- Stock Market
- Equities
- A298060 Stock
